Advocacy Update – April 2023: Spring on Capitol Hill
On Tuesday, December 20, 2022, lawmakers unveiled their long-awaited $1.7 trillion government funding package. The package includes 12...
Read: Advocacy Update – April 2023: Spring on Capitol HillLatest News -Press Room
Advocacy Update – March 2023: Federal Appropriations 101 and Why Advocacy Matters for Mito
On Tuesday, December 20, 2022, lawmakers unveiled their long-awaited $1.7 trillion government funding package. The package includes 12...
Read: Advocacy Update – March 2023: Federal Appropriations 101 and Why Advocacy Matters for MitoReata Pharmaceuticals Announces FDA Approval of SKYCLARYS™ (Omaveloxolone) for Friedreich’s Ataxia. Learn What this Means for the Mito Community.
Cyclerion Therapeutics to Discuss CY6463 MELAS Clinical Data at a Webinar Hosted by United Mitochondrial Disease Foundation Company to...
Read: Reata Pharmaceuticals Announces FDA Approval of SKYCLARYS™ (Omaveloxolone) for Friedreich’s Ataxia. Learn What this Means for the Mito Community.Research Update from 2015 UMDF Grant Recipient Sara Nowinski, PhD
In 2015, Sara Nowinski, PhD received a $70,000 grant award for her work “Characterizing the Function of the Atypical Mitochondrial Kinase...
Read: Research Update from 2015 UMDF Grant Recipient Sara Nowinski, PhDAdvocacy Update – February 2023: Could ARPA-H Change the Research Landscape for Rare Diseases?
On Tuesday, December 20, 2022, lawmakers unveiled their long-awaited $1.7 trillion government funding package. The package includes 12...
Read: Advocacy Update – February 2023: Could ARPA-H Change the Research Landscape for Rare Diseases?Advocacy Update – January 2023: What Does 2023 Hold for Mito Advocacy?
On Tuesday, December 20, 2022, lawmakers unveiled their long-awaited $1.7 trillion government funding package. The package includes 12...
Read: Advocacy Update – January 2023: What Does 2023 Hold for Mito Advocacy?Advocacy Update – December 2022: Mito Research Funding Looks Headed for Renewal in Newly Unveiled Funding Bill
On Tuesday, December 20, 2022, lawmakers unveiled their long-awaited $1.7 trillion government funding package. The package includes 12...
Read: Advocacy Update – December 2022: Mito Research Funding Looks Headed for Renewal in Newly Unveiled Funding Billaccelerators Research Update from Rachel Guerra, PhD, UMDF Funded Runner-Up from Big Pitch 2019
Research Update At the very first The Big Pitch Event at the UMDF Symposium for Mitochondrial Medicine in 2019, three candidates had five...
Read: accelerators Research Update from Rachel Guerra, PhD, UMDF Funded Runner-Up from Big Pitch 2019Advocacy Update – September 2022: Three Things You Should Ask of Congress as We Wrap Up World Mitochondrial Disease Week
This week, as part of World Mitochondrial Disease Week, UMDF President & CEO Brian Harman caught up with the offices of several members of...
Read: Advocacy Update – September 2022: Three Things You Should Ask of Congress as We Wrap Up World Mitochondrial Disease WeekUMDF Marks World Mitochondrial Disease Week, September 18 – 24, 2022
This week, as part of World Mitochondrial Disease Week, UMDF President & CEO Brian Harman caught up with the offices of several members of...
Read: UMDF Marks World Mitochondrial Disease Week, September 18 – 24, 2022